Alteration of biological markers in alcohol-dependent individuals without liver disease during the detoxification therapy

In Vivo

Volumn 24, Issue 3, 2010, Pages 325-328

  Chatzipanagiotou, Stylianos ^a   Kalykaki, Maria ^a   Tzavellas, Elias ^a   Karaiskos, Dimitrios ^a   Paparrigopoulos, Thomas ^a   Liappas, Alexander ^b   Nicolaou, Chryssoula ^a   Michalopoulou, Maria ^a   Zoga, Margarita ^a   Boufidou, Fotini ^a   Liappas, Ioannis ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

Author keywords

Alcohol abuse; Biomarkers; CDT; IL 6

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; CARBOHYDRATE DEFICIENT TRANSFERRIN; INTERLEUKIN 6;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CYTOKINE RELEASE; DETOXIFICATION; DIAGNOSTIC VALUE; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; LIVER FUNCTION; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR VOLUME;

EID: 77954125045     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Wolfang Settertobulte, Bjarne Jensen and Klaus Hurrelmann. Drinking among young Europeans. WHO European ministerial conference on young people and alcohol. Stockholm, 2001.
2. Orley J and Logan D: Perspectives on Partnerships for corporate social responsibility in the beverage alcohol industry. Chapter 4. In: Corporate Social Responsibility and Alcohol. Marcus G and O'Connor J (eds.)., 2005.
3. Harper C: The neuropathology of alcohol-related brain damage. Alcohol Alcohol 44: 136-140, 2009.
4. Sharpe PC: Biochemical detection and monitoring of alcohol abuse and abstinence. Ann Clin Biochem 38: 652-664, 2001. (Pubitemid 33702271)
5. Niemela O: Biomarkers in alcoholism. Clin Chim Acta 377: 39-49, 2007.
6. Liappas IA, Nicolaou C, Chatzipanagiotou S, Tzavellas EO, Piperi C, Papageorgiou C, Boufidou F, Bagos P and Soldatos CR: Vitamin B12 and hepatic enzyme serum levels correlate with interleukin-6 in alcohol-dependent individuals without liver disease. Clin Biochem 40: 781-786, 2007.
7. Imbert-Bismut F, Naveau S, Morra R, Munteanu M, Ratziu V, Abella A, Messous D, Thabut D, Benhamou Y and Poynard T: The diagnostic value of combining carbohydrate-deficient transferrin, fibrosis, and steatosis biomarkers for the prediction of excessive alcohol consumption. Eur J Gastroenterol Hepatol 21: 18-27, 2009.
8. Mundle G, Ackermann K, Munkes J, Steinte D and Mann K: Influence of age, alcohol consumption and abstinence on the sensitivity of carbohydrate-deficient transferrin, gamma-glutamyltransferase and mean corpuscular volume. Alcohol Alcohol 34: 760-766, 1999.
9. Hock B, Schwarz M, Domke I, Grunert VP, Wuertemberger M, Schiemann U, Horster S, Limmer C, Stecker G and Soyka M: Validity of carbohydrate-deficient transferrin (%CDT), gamma-glutamyltransferase (gamma-GT) and mean corpuscular erythrocyte volume (MCV) as biomarkers for chronic alcohol abuse: a study in patients with alcohol dependence and liver disorders of non-alcoholic and alcoholic origin. Addiction 100: 1477-1486, 2005. (Pubitemid 41442317)
10. Hietala J, Koivisto H, Anttila P and Niemela O: Comparison of the combined marker GGT-CDT and the conventional laboratory markers of alcohol abuse in heavy drinkers, moderate drinkers and abstainers. Alcohol Alcohol 41: 528-533, 2006.
11. Godart B, Mennetrey L, Schellenberg F, Pages JC and Bacq Y: Carbohydrate-deficient transferrin and gamma-glutamyl transpeptidase in the evaluation of alcohol consumption. A five-year retrospective study of 633 outpatients in a single center. Gastroenterol Clin Biol 29: 113-116, 2005.
12. Rinck D, Frieling H, Freitag A, Hillemacher T, Bayerlein K, Kornhuber J and Bleich S: Combinations of carbohydrate-deficient transferrin, mean corpuscular erythrocyte volume, gamma-glutamyltransferase, homocysteine and folate increase the significance of biological markers in alcohol dependent patients. Drug Alcohol Depend 89: 60-65, 2007.
13. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders 4th Edition. Washington DC, 1994.
14. Janca A, Ustün TB, Sartorius N: New versions of World Health Organization instruments for the assessment of mental disorders. Acta Psychiatr Scand 90(2): 73-83 Review, 1991.
15. Robins LN, Wing J, Wittchen HU, Helzer JE, Babor TF, Burke J, Farmer A, Jabienski A, Pickens R, Regier DA et al: The Composite International Diagnostic Interview. An epidemiological instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch Gen Psychiatry 45(12): 1069-1077, 1988.
16. Hughes PH, Venulet J, Khant U, Medina Mora ME, Navaratnam V, Poshyachinda V, Rootman I, Salan R and Wadud KA: Core data for epidemiological studies on nonmedical drug use. WHO Offset Publication 56. Geneva: World Health Organization, pp. 1-100, 1980.
17. Anttila P, Jarvi K, Latvala J, Romppanen J, Punnonen K and Niemela O: Biomarkers of alcohol consumption in patients classified according to the degree of liver disease severity. Scand J Clin Lab Invest 65: 141-151, 2005. (Pubitemid 40571150)
18. Maruyama S, Hirayama C, Yamamoto S, Koda M, Udagawa A, Kadowaki Y, Inoue M, Sagayama A and Umeki K: Red blood cell status in alcoholic and non-alcoholic liver disease. J Lab Clin Med 138: 332-337, 2001.
19. Hannuksela ML, Liisanantti MK, Nissinen AE and Savolainen MJ: Biochemical markers of alcoholism. Clin Chem Lab Med 45: 953-961, 2007.
20. Das SK, Dhanya L and Vasudevan DM: Biomarkers of alcoholism: an updated review. Scand J Clin Lab Invest 68: 81-92, 2008.
21. Puukka K, Hietala J, Koivisto H, Anttila P, Bloigu R and Niemela O: Obesity and the clinical use of serum GGT activity as a marker of heavy drinking. Scand J Clin Lab Invest 67: 480-488, 2007.
22. Hietala J, Puukka K, Koivisto H, Anttila P and Niemela O: Serum gamma-glutamyl transferase in alcoholics, moderate drinkers and abstainers: effect on GT reference intervals at population level. Alcohol Alcohol 40: 511-514, 2005.
23. Stibler H: Carbohydrate-deficient transferrin in serum: a new marker of potentially harmful alcohol consumption reviewed. Clin Chem 37: 2029-2037, 1991.
24. Bortolotti F, De Paoli G and Tagliaro F: Carbohydrate-deficient transferrin (CDT) as a marker of alcohol abuse: a critical review of the literature 2001-2005. J Chromatogr B Analyt Technol Biomed Life Sci 841: 96-109, 2006.
25. Anton RF: Carbohydrate-deficient transferrin for detection and monitoring of sustained heavy drinking. What have we learned? Where do we go from here? Alcohol 25: 185-188, 2001.
26. Sillanaukee P, Strid N, Allen JP and Litten RZ: Possible reasons why heavy drinking increases carbohydrate-deficient transferrin. Alcohol Clin Exp Res 25: 34-40, 2001. (Pubitemid 32147691)
27. Chrostek L, Cylwik B, Szmitkowski M and Korcz W: The diagnostic accuracy of carbohydrate-deficient transferrin, sialic acid and commonly used markers of alcohol abuse during abstinence. Clin Chim Acta 364: 167-171, 2006.
28. Rosalki SB: Carbohydrate-deficient transferrin: a marker of alcohol abuse. Int J Clin Pract 58: 391-393, 2004.
29. Latvala J, Hietala J, Koivisto H, Jarvi K, Anttila P and Niemela O: Immune responses to ethanol metabolites and cytokine profiles differentiate alcoholics with or without liver disease. Am J Gastroenterol 100: 1303-1310, 2005.